Access cutting-edge postoperative cognitive decline treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Rochester location
Preparing your pre-screening questions…
Access postoperative cognitive decline specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related postoperative cognitive decline treatment provided free
Check if you qualify for this postoperative cognitive decline clinical trial in Rochester, NY
No-Cost Study Care
Local to Rochester
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this follow-on pilot randomized clinical trial is to obtain additional preliminary data to inform a larger, adequately powered phase 2b trial of daridorexant for the prevention of postoperative delirium after heart surgery. Having demonstrated feasibility in a prior study (RSRB #9841), this study aims to estimate the effect of daridorexant on (1) reducing delirium symptom burden and incidence and (2) improving self-reported sleep quality during the postoperative period, and (3) to assess the feasibility of collecting objective sleep data in the postoperative setting. Participants will: complete a baseline visit; take the study drug, either daridorexant or placebo, each of the first three nights after heart surgery; and be evaluated daily for sleep and delirium during the first three postoperative days. Participants will also have the option of wearing a sleep monitor in the hospital each of the first three nights after surgery.
Sponsor: University of Rochester
Yes, this clinical trial (NCT07217912) has an active research site in Rochester, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for postoperative cognitive decline treatment options in Rochester, NY, this clinical trial (NCT07217912) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced postoperative cognitive decline specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all postoperative cognitive decline clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Rochester — not just this study.
Browse Pulmonary Embolism Trials in Rochester →